Found: 148
Select item for more details and to access through your institution.
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2230663
- By:
- Publication type:
- Article
A successful management of refractory immune thrombocytopenic purpura with Eltrombopag during pregnancy complicated with superimposed preeclampsia.
- Published in:
- Oxford Medical Case Reports, 2023, v. 2023, n. 5, p. 1, doi. 10.1093/omcr/omad047
- By:
- Publication type:
- Article
PP025 Thrombopoietin Receptor Agonist For Treatment Of Adults With Chronic Immune Thrombocytopenic Purpura.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.953716
- By:
- Publication type:
- Article
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.019
- By:
- Publication type:
- Article
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.021
- By:
- Publication type:
- Article
Successful Treatment with Thrombopoietin Receptor Agonist in Avoiding Splenectomy for Patients with Chronic Refractory Immune Thrombocytopenia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2012, v. 4, n. 1, p. 1, doi. 10.4084/MJHID.2012.003
- By:
- Publication type:
- Article
The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence.
- Published in:
- International Journal of Hepatology, 2016, p. 1, doi. 10.1155/2016/1802932
- By:
- Publication type:
- Article
Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS‐IT).
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: A multicenter real‐world retrospective study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 407, doi. 10.1111/ejh.14021
- By:
- Publication type:
- Article
Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 5, p. 548, doi. 10.1111/ejh.13929
- By:
- Publication type:
- Article
Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 3, p. 304, doi. 10.1111/ejh.13014
- By:
- Publication type:
- Article
Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 4, p. 372, doi. 10.1111/ejh.12932
- By:
- Publication type:
- Article
ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats.
- Published in:
- Journal of Veterinary Internal Medicine, 2024, v. 38, n. 4, p. 1982, doi. 10.1111/jvim.17079
- By:
- Publication type:
- Article
Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center.
- Published in:
- Acta Médica Portuguesa, 2024, v. 37, n. 4, p. 294, doi. 10.20344/amp.20532
- By:
- Publication type:
- Article
Indirect hyperbilirubinemia because of eltrombopag in two cases after autologous hematopoetic stem cell transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Indirect hyperbilirubinemia because of eltrombopag in two cases after autologous hematopoetic stem cell transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 11, p. 1372, doi. 10.3390/antibiotics10111372
- By:
- Publication type:
- Article
Ayurveda and Allopathic Therapeutic Strategies in Immune Thrombocytopenic Purpura: An Overview.
- Published in:
- Turkish Journal of Immunology, 2023, v. 11, n. 2, p. 42, doi. 10.4274/tji.galenos.2023.81894
- By:
- Publication type:
- Article
Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1393829
- By:
- Publication type:
- Article
Aplastic Anemia Treated with Eltrombopag during Pregnancy.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2022, p. 1, doi. 10.1155/2022/5889427
- By:
- Publication type:
- Article
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267342
- By:
- Publication type:
- Article
Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2163, doi. 10.3390/ijms25042163
- By:
- Publication type:
- Article
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10975-3
- By:
- Publication type:
- Article
Imunitní trombocytopenie v dětském věku.
- Published in:
- Pediatrie pro Praxi, 2022, v. 23, n. 5, p. 326, doi. 10.36290/ped.2022.057
- By:
- Publication type:
- Article
Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 6, p. 1, doi. 10.1111/tid.14163
- By:
- Publication type:
- Article
Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2021.790686
- By:
- Publication type:
- Article
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study.
- Published in:
- Journal of Blood Medicine, 2024, v. 15, p. 217, doi. 10.2147/JBM.S457545
- By:
- Publication type:
- Article
Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 337, doi. 10.2147/JBM.S358993
- By:
- Publication type:
- Article
Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS.
- Published in:
- International Journal of Analytical Chemistry, 2020, p. 1, doi. 10.1155/2020/7290470
- By:
- Publication type:
- Article
POOR GRAFT FUNCTION – CAUSES AND POTENTIAL SOLUTIONS.
- Published in:
- Medical Review / Medicinski Pregled, 2022, v. 75, p. 45, doi. 10.2298/MPNS22S1045T
- By:
- Publication type:
- Article
Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists.
- Published in:
- Transfusion, 2013, v. 53, n. 11, p. 2807, doi. 10.1111/trf.12139
- By:
- Publication type:
- Article
THROMBOPOIETIN RECEPTOR AGONISTS AND OTHER SECOND-LINE THERAPIES FOR IMMUNE THROMBOCYTOPENIA: A NARRATIVE REVIEW WITH A FOCUS ON DRUG ACCESS IN CANADA.
- Published in:
- Clinical & Investigative Medicine, 2024, v. 47, n. 1, p. 13, doi. 10.3138/cim-2024-2569
- By:
- Publication type:
- Article
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
- Published in:
- Systematic Reviews, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s13643-024-02515-2
- By:
- Publication type:
- Article
Tooth Extraction in a Hepatic Cirrhosis Patient Receiving the Novel Oral Thrombopoietin Receptor agonist Lusutrombopag.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives.
- Published in:
- Therapeutics & Clinical Risk Management, 2022, v. 18, p. 273, doi. 10.2147/TCRM.S251672
- By:
- Publication type:
- Article
Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma.
- Published in:
- Mediators of Inflammation, 2017, p. 1, doi. 10.1155/2017/7582079
- By:
- Publication type:
- Article
Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 142, doi. 10.1111/bjh.12186
- By:
- Publication type:
- Article
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 811, doi. 10.1111/j.1365-2141.2012.09227.x
- By:
- Publication type:
- Article
Hetrombopag, a Thrombopoietin Receptor Agonist, Protects Cardiomyocyte Survival from Oxidative Stress Damage as an Enhancer of Stem Cells.
- Published in:
- Cardiovascular Drugs & Therapy, 2016, v. 30, n. 6, p. 567, doi. 10.1007/s10557-016-6696-8
- By:
- Publication type:
- Article
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296211073920
- By:
- Publication type:
- Article
Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211005555
- By:
- Publication type:
- Article
SINGLE-CENTRE REAL-LIFE EXPERIENCE ON THE USE OF THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CHILDREN.
- Published in:
- Farmacia, 2024, v. 72, n. 1, p. 185, doi. 10.31925/farmacia.2024.1.20
- By:
- Publication type:
- Article
EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS IN MODERN TREATMENT OF IMMUNE THROMBOCYTOPENIA.
- Published in:
- Farmacia, 2021, v. 69, n. 2, p. 219, doi. 10.31925/farmacia.2021.2.5
- By:
- Publication type:
- Article
Current management of relapsed/refractory immune thrombocytopenia.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 15
- By:
- Publication type:
- Article
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53209-y
- By:
- Publication type:
- Article
Eltrombopag‐associated erythromelalgia in idiopathic thrombocytopenic purpura.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 3, p. 585, doi. 10.1111/bjd.20829
- By:
- Publication type:
- Article
Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations.
- Published in:
- 2022
- By:
- Publication type:
- Case Study